GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » Change In Other Working Capital

Cangene (FRA:YGE) Change In Other Working Capital : €0.34 Mil (TTM As of Oct. 2013)


View and export this data going back to . Start your Free Trial

What is Cangene Change In Other Working Capital?

Cangene's Change In Other Working Capital for the quarter that ended in Oct. 2013 was €0.21 Mil. It means Cangene's Other Working Capital increased by €0.21 Mil from Jul. 2013 to Oct. 2013 .

Cangene's Change In Other Working Capital for the fiscal year that ended in Jul. 2013 was €0.69 Mil. It means Cangene's Other Working Capital increased by €0.69 Mil from Jul. 2012 to Jul. 2013 .

Cangene Change In Other Working Capital Historical Data

The historical data trend for Cangene's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene Change In Other Working Capital Chart

Cangene Annual Data
Trend Jul04 Jul05 Jul06 Jul07 Jul08 Jul09 Jul10 Jul11 Jul12 Jul13
Change In Other Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 1.25 -0.03 0.69

Cangene Quarterly Data
Jan09 Apr09 Jul09 Oct09 Jan10 Apr10 Jul10 Oct10 Jan11 Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 0.06 -0.28 0.35 0.21

Cangene Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Oct. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.34 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cangene Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Cangene's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Cangene (FRA:YGE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » Change In Other Working Capital
Comparable Companies
ASX:NEU OSTO:IBT B XKRX:115180 ROCO:6657 WBO:MARI XPAR:TNG CNCE ROCO:6575 EVLO ALDX HKSE:01035 XFOR GMDA MIRM TSXV:ACST XPAR:NANO OCSE:ORPHA XYNO SLGL AQST
Traded in Other Exchanges
N/A
Address
Website
http://www.cangene.com
Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines